STACEY BERG

Concepts (344)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
31
2021
1686
2.480
Why?
Neoplasms
35
2024
2789
2.130
Why?
Leukemia
10
2019
369
1.030
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1252
0.890
Why?
Pyrimidines
6
2024
371
0.840
Why?
Thalidomide
3
2011
36
0.780
Why?
Neuroblastoma
7
2021
520
0.760
Why?
Arabinonucleosides
3
2006
32
0.760
Why?
Protein Kinase Inhibitors
6
2021
539
0.730
Why?
Azepines
3
2019
63
0.680
Why?
Medical Oncology
4
2010
214
0.670
Why?
Vincristine
2
2021
192
0.640
Why?
Meningeal Neoplasms
7
2011
185
0.630
Why?
Neoplasm Recurrence, Local
13
2024
1148
0.630
Why?
Maximum Tolerated Dose
14
2024
162
0.550
Why?
Child
50
2024
24399
0.550
Why?
Salvage Therapy
5
2019
192
0.540
Why?
Antineoplastic Agents, Alkylating
4
2010
101
0.530
Why?
Child, Preschool
38
2024
14018
0.520
Why?
Drug Therapy
1
2016
87
0.520
Why?
Antineoplastic Agents, Phytogenic
2
2015
100
0.520
Why?
Piperazines
4
2024
238
0.510
Why?
Pharmaceutical Preparations
1
2016
79
0.500
Why?
Drugs, Essential
3
2023
7
0.500
Why?
Macaca mulatta
12
2011
491
0.490
Why?
Benzimidazoles
2
2022
132
0.480
Why?
Dacarbazine
3
2011
95
0.480
Why?
Central Nervous System Neoplasms
4
2024
196
0.470
Why?
Oxygenases
1
2014
4
0.470
Why?
Daunorubicin
1
2014
27
0.460
Why?
Histone Deacetylase Inhibitors
3
2012
74
0.460
Why?
Glutathione S-Transferase pi
1
2014
25
0.460
Why?
O(6)-Methylguanine-DNA Methyltransferase
3
2009
20
0.460
Why?
Peripheral Nervous System Diseases
1
2015
125
0.450
Why?
Adolescent
39
2024
19336
0.450
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2020
781
0.450
Why?
Microtubule-Associated Proteins
1
2015
246
0.440
Why?
Decision Support Techniques
1
2016
292
0.430
Why?
Drug Resistance, Neoplasm
9
2024
724
0.430
Why?
Area Under Curve
12
2021
317
0.420
Why?
Antibiotics, Antineoplastic
3
2014
126
0.420
Why?
Clinical Trials, Phase I as Topic
2
2010
60
0.420
Why?
Young Adult
21
2024
9047
0.390
Why?
Hydroxamic Acids
1
2012
55
0.390
Why?
Guanine
3
2011
61
0.390
Why?
Camptothecin
3
2008
73
0.390
Why?
Enzyme Inhibitors
5
2009
579
0.380
Why?
Doxorubicin
2
2014
289
0.380
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2024
30
0.380
Why?
Informed Consent
3
2009
334
0.380
Why?
Sarcoma, Ewing
3
2022
107
0.380
Why?
Patient Participation
3
2010
220
0.360
Why?
Humans
68
2024
124867
0.350
Why?
Male
49
2024
61375
0.350
Why?
Body Composition
2
2014
522
0.350
Why?
Obesity
2
2014
2237
0.340
Why?
Dose-Response Relationship, Drug
10
2018
1692
0.340
Why?
Metabolic Clearance Rate
5
2014
144
0.340
Why?
Myelodysplastic Syndromes
1
2010
140
0.320
Why?
Antimetabolites, Antineoplastic
4
2020
184
0.310
Why?
Chromatography, High Pressure Liquid
8
2011
343
0.310
Why?
Carboxylic Acids
1
2008
24
0.310
Why?
Medulloblastoma
2
2012
325
0.310
Why?
Rhabdomyosarcoma
2
2022
190
0.310
Why?
Infant
21
2024
12473
0.310
Why?
Boronic Acids
2
2005
47
0.310
Why?
Cyclophosphamide
2
2008
418
0.300
Why?
Oligopeptides
1
2008
116
0.300
Why?
Pyrazines
2
2005
75
0.300
Why?
Physician-Patient Relations
2
2009
430
0.300
Why?
Cyclin-Dependent Kinase 6
2
2024
41
0.280
Why?
Cyclin-Dependent Kinase 4
2
2024
58
0.280
Why?
Clinical Trials as Topic
2
2009
1092
0.280
Why?
Phthalazines
2
2024
13
0.270
Why?
Female
42
2024
66655
0.270
Why?
Polymorphism, Single Nucleotide
1
2015
2635
0.270
Why?
Infusions, Intravenous
8
2005
556
0.260
Why?
Indoles
2
2004
187
0.260
Why?
Topotecan
3
2012
48
0.250
Why?
Leukemia, T-Cell
1
2005
11
0.250
Why?
Ethics, Medical
2
2007
395
0.240
Why?
Protease Inhibitors
1
2005
95
0.240
Why?
DNA Repair
3
2024
585
0.240
Why?
Cell Line, Tumor
6
2018
3343
0.230
Why?
Cyclopentanes
1
2024
20
0.230
Why?
Cyclin D1
1
2004
112
0.230
Why?
Depsipeptides
1
2004
10
0.230
Why?
Cyclins
1
2004
101
0.230
Why?
Carbazoles
1
2004
33
0.220
Why?
Cisplatin
2
2004
242
0.220
Why?
Peptides, Cyclic
1
2004
53
0.220
Why?
Parents
3
2009
1023
0.210
Why?
Rhabdoid Tumor
1
2023
47
0.210
Why?
Glioma
2
2022
491
0.210
Why?
Pyridines
1
2024
230
0.200
Why?
Methotrexate
2
2020
341
0.200
Why?
Proto-Oncogene Proteins B-raf
1
2024
188
0.200
Why?
Adult
19
2024
29562
0.190
Why?
Models, Theoretical
1
2004
359
0.190
Why?
TOR Serine-Threonine Kinases
1
2024
430
0.190
Why?
Treatment Outcome
14
2020
12398
0.190
Why?
Dactinomycin
1
2021
66
0.180
Why?
Maytansine
1
2020
3
0.180
Why?
Neurofibrosarcoma
1
2020
5
0.180
Why?
Injections, Spinal
6
2011
124
0.180
Why?
Pulmonary Blastoma
1
2020
11
0.180
Why?
Sarcoma, Synovial
1
2020
21
0.170
Why?
Sodium Bicarbonate
1
2020
54
0.170
Why?
Drug Synergism
3
2009
229
0.170
Why?
Protein-Tyrosine Kinases
2
2019
208
0.170
Why?
Drug Interactions
3
2012
253
0.160
Why?
National Cancer Institute (U.S.)
3
2024
32
0.160
Why?
Wilms Tumor
1
2020
113
0.160
Why?
Cerebrospinal Fluid
3
2004
94
0.160
Why?
Research Subjects
1
2019
54
0.160
Why?
Drug Administration Schedule
6
2018
726
0.150
Why?
Antineoplastic Agents, Immunological
1
2020
118
0.150
Why?
Lymphoma, Non-Hodgkin
1
2020
163
0.150
Why?
Antibodies, Monoclonal
2
2024
1031
0.150
Why?
Topoisomerase I Inhibitors
2
2011
16
0.150
Why?
Bone Neoplasms
2
2019
418
0.150
Why?
Research Personnel
1
2019
118
0.150
Why?
Inhibitory Concentration 50
3
2014
77
0.150
Why?
Furans
1
2018
28
0.150
Why?
Ketones
1
2018
26
0.150
Why?
Recurrence
3
2019
1420
0.140
Why?
Health Services Accessibility
2
2023
607
0.140
Why?
Cell Cycle Proteins
2
2019
642
0.140
Why?
Aurora Kinase A
1
2018
39
0.140
Why?
Animals
16
2019
34046
0.140
Why?
Hodgkin Disease
1
2020
292
0.140
Why?
Cell Survival
2
2012
807
0.140
Why?
Health Policy
1
2019
212
0.140
Why?
Mass Spectrometry
3
2006
330
0.130
Why?
Brain Neoplasms
2
2004
1216
0.130
Why?
Health Care Rationing
1
2016
58
0.120
Why?
Palliative Care
1
2019
429
0.120
Why?
Pediatrics
3
2010
1165
0.120
Why?
Deoxycytidine
2
2007
78
0.120
Why?
Molecular Targeted Therapy
2
2022
361
0.110
Why?
Drug Screening Assays, Antitumor
1
2014
93
0.110
Why?
Prodrugs
2
2006
58
0.110
Why?
Glioblastoma
1
2018
330
0.110
Why?
Absorptiometry, Photon
1
2014
177
0.110
Why?
Separase
1
2014
29
0.110
Why?
Clinical Decision-Making
1
2016
266
0.110
Why?
Biomedical Research
1
2019
519
0.110
Why?
Pregnancy Complications, Neoplastic
1
2014
62
0.110
Why?
Mutation
2
2024
5845
0.110
Why?
Pharmacogenetics
1
2014
184
0.110
Why?
Tumor Cells, Cultured
2
2005
1063
0.110
Why?
Practice Guidelines as Topic
2
2017
1268
0.100
Why?
Injections, Intravenous
3
2008
250
0.100
Why?
Neoplasm Staging
2
2008
1278
0.100
Why?
Haplotypes
1
2014
522
0.100
Why?
Meningitis, Aseptic
1
2012
13
0.100
Why?
Aurora Kinase B
1
2012
7
0.100
Why?
Aurora Kinases
1
2012
31
0.100
Why?
Pyrroles
2
2024
178
0.100
Why?
Mitogen-Activated Protein Kinases
2
2024
207
0.100
Why?
Models, Statistical
1
2014
472
0.090
Why?
Survival Rate
4
2019
2060
0.090
Why?
Genomics
1
2019
1502
0.090
Why?
Brain Stem Neoplasms
1
2011
39
0.090
Why?
Polymorphism, Genetic
1
2014
812
0.090
Why?
Half-Life
4
2021
157
0.090
Why?
Prognosis
4
2019
4631
0.090
Why?
Lung Neoplasms
1
2021
1660
0.090
Why?
Organoplatinum Compounds
1
2010
28
0.090
Why?
Blood-Brain Barrier
2
2018
143
0.090
Why?
Disease Models, Animal
4
2019
4351
0.090
Why?
Altruism
1
2010
24
0.090
Why?
United States
6
2024
10906
0.090
Why?
Immunity, Cellular
1
2010
205
0.080
Why?
Apoptosis
3
2018
1796
0.080
Why?
Survival Analysis
3
2020
1507
0.080
Why?
DNA Mismatch Repair
1
2009
49
0.080
Why?
Drug Discovery
1
2010
171
0.080
Why?
Tissue Distribution
2
2019
390
0.080
Why?
Acyclovir
1
2008
45
0.080
Why?
Bortezomib
2
2005
73
0.080
Why?
Valine
1
2008
112
0.070
Why?
Body Mass Index
1
2014
1562
0.070
Why?
Carmustine
1
2008
26
0.070
Why?
Confidentiality
1
2008
99
0.070
Why?
Follow-Up Studies
4
2019
5163
0.070
Why?
Human Experimentation
1
2007
36
0.070
Why?
Ethics, Research
1
2007
51
0.070
Why?
Carboplatin
2
2004
76
0.070
Why?
Genome-Wide Association Study
1
2014
1685
0.070
Why?
Administration, Intravenous
2
2020
145
0.070
Why?
Erythropoietin
1
2007
104
0.070
Why?
DNA Damage
2
2024
513
0.070
Why?
Benzamides
2
2023
108
0.070
Why?
Valproic Acid
1
2007
163
0.070
Why?
Immunocompromised Host
1
2008
293
0.060
Why?
Proto-Oncogene Proteins c-mdm2
1
2006
79
0.060
Why?
Adenine Nucleotides
1
2005
41
0.060
Why?
Risk
1
2007
754
0.060
Why?
Xenograft Model Antitumor Assays
2
2019
889
0.060
Why?
Administration, Oral
3
2018
682
0.060
Why?
Imidazoles
1
2006
202
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
1
2005
173
0.060
Why?
Cyclin D3
1
2004
10
0.060
Why?
Cyclin D2
1
2004
14
0.060
Why?
Cyclin D
1
2024
6
0.060
Why?
Proteasome Inhibitors
1
2004
61
0.060
Why?
NEDD8 Protein
1
2024
11
0.060
Why?
Thiophenes
1
2005
58
0.060
Why?
Heat-Shock Proteins
1
2005
195
0.060
Why?
Prospective Studies
2
2021
6148
0.060
Why?
Retinoblastoma Protein
1
2004
78
0.060
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2024
39
0.060
Why?
BRCA2 Protein
1
2024
45
0.060
Why?
Cyclin-Dependent Kinases
1
2004
86
0.060
Why?
BRCA1 Protein
1
2024
68
0.060
Why?
Ataxia Telangiectasia Mutated Proteins
1
2024
96
0.060
Why?
Quinazolines
1
2005
174
0.060
Why?
Aminopyridines
1
2024
55
0.050
Why?
SMARCB1 Protein
1
2023
38
0.050
Why?
Anemia
1
2007
339
0.050
Why?
Neoplasm Proteins
1
2008
671
0.050
Why?
Enhancer of Zeste Homolog 2 Protein
1
2023
63
0.050
Why?
Phenylacetates
1
2003
23
0.050
Why?
Nuclear Proteins
2
2023
1265
0.050
Why?
Drug Administration Routes
1
2003
32
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2024
336
0.050
Why?
Ipilimumab
1
2022
62
0.050
Why?
Physicians
1
2009
581
0.050
Why?
MAP Kinase Signaling System
1
2024
313
0.050
Why?
Germ-Line Mutation
1
2024
332
0.050
Why?
DNA Helicases
1
2023
231
0.050
Why?
Mixed Function Oxygenases
1
2002
30
0.050
Why?
Cell Cycle
1
2004
611
0.050
Why?
Glutamine
1
2003
215
0.050
Why?
Europe
1
2023
353
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2022
89
0.050
Why?
Phenytoin
1
2002
64
0.050
Why?
DNA-Binding Proteins
2
2024
2043
0.050
Why?
Lymphoma
1
2005
322
0.050
Why?
Vascular Endothelial Growth Factor A
1
2024
408
0.050
Why?
Proto-Oncogene Proteins
1
2004
544
0.050
Why?
Cytochrome P-450 Enzyme System
1
2002
134
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2022
157
0.050
Why?
CD56 Antigen
1
2020
26
0.040
Why?
Clinical Protocols
1
2022
241
0.040
Why?
Decision Making
1
2006
656
0.040
Why?
Biomarkers, Tumor
2
2019
1492
0.040
Why?
Response Evaluation Criteria in Solid Tumors
1
2020
8
0.040
Why?
Surveys and Questionnaires
1
2010
3728
0.040
Why?
DNA Repair Enzymes
2
2011
39
0.040
Why?
DNA Modification Methylases
2
2011
44
0.040
Why?
Pyrimidinones
1
2019
49
0.040
Why?
Drugs, Generic
1
2019
13
0.040
Why?
Community Participation
1
2019
44
0.040
Why?
Sodium
1
2020
295
0.040
Why?
Retreatment
1
2019
89
0.040
Why?
Anticonvulsants
1
2002
377
0.040
Why?
Risk Assessment
2
2005
3448
0.040
Why?
Patient Rights
1
2019
51
0.040
Why?
Focus Groups
1
2019
199
0.040
Why?
Family
2
2016
566
0.040
Why?
Combined Modality Therapy
3
2008
1240
0.040
Why?
Multimodal Imaging
1
2019
114
0.040
Why?
Algorithms
1
2005
1624
0.040
Why?
Microtubules
1
2018
195
0.030
Why?
Time Factors
2
2004
6319
0.030
Why?
Pyrazoles
1
2019
305
0.030
Why?
Immunophenotyping
1
2018
330
0.030
Why?
Neoplasm Grading
1
2018
274
0.030
Why?
Tumor Suppressor Proteins
2
2011
465
0.030
Why?
Dexamethasone
2
2012
275
0.030
Why?
Flow Cytometry
1
2018
798
0.030
Why?
United States Food and Drug Administration
1
2016
149
0.030
Why?
Patient Safety
1
2019
401
0.030
Why?
Interdisciplinary Communication
1
2016
131
0.030
Why?
Proportional Hazards Models
2
2011
1358
0.030
Why?
Pilot Projects
1
2018
1397
0.030
Why?
Rhodamines
1
2014
22
0.030
Why?
Immunohistochemistry
1
2018
1691
0.030
Why?
Infant, Newborn
3
2017
8199
0.030
Why?
Hydrolysis
1
2014
161
0.030
Why?
Transcription Factors
1
2023
2582
0.030
Why?
High-Throughput Screening Assays
1
2014
96
0.030
Why?
Neoplasm Transplantation
1
2014
374
0.030
Why?
Mice
3
2019
17573
0.030
Why?
Infusions, Intraventricular
1
2012
13
0.030
Why?
Microscopy, Fluorescence
1
2014
325
0.030
Why?
Antibodies
1
2014
374
0.020
Why?
Retrospective Studies
3
2020
16336
0.020
Why?
Phosphoproteins
1
2014
404
0.020
Why?
Ki-67 Antigen
1
2011
113
0.020
Why?
Age Factors
2
2008
2822
0.020
Why?
Peptides
1
2014
798
0.020
Why?
Health Insurance Portability and Accountability Act
1
2008
19
0.020
Why?
State Government
1
2008
29
0.020
Why?
Biomarkers
1
2018
3069
0.020
Why?
Government Regulation
1
2008
41
0.020
Why?
Kaplan-Meier Estimate
1
2011
1053
0.020
Why?
Drug Therapy, Combination
1
2011
1165
0.020
Why?
Darbepoetin alfa
1
2007
15
0.020
Why?
Pharmacokinetics
1
2007
16
0.020
Why?
Microsatellite Instability
1
2007
36
0.020
Why?
Radiotherapy Dosage
1
2008
183
0.020
Why?
Bone Marrow Diseases
1
2008
41
0.020
Why?
DNA, Neoplasm
1
2008
301
0.020
Why?
Hematinics
1
2007
55
0.020
Why?
Cell Proliferation
1
2014
2290
0.020
Why?
HCT116 Cells
1
2006
55
0.020
Why?
Stem Cell Transplantation
1
2008
231
0.020
Why?
Hemoglobins
1
2007
309
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
257
0.020
Why?
Pulse Therapy, Drug
1
2004
7
0.010
Why?
Middle Aged
3
2014
26867
0.010
Why?
Biological Availability
1
2004
136
0.010
Why?
Meningitis
1
2005
99
0.010
Why?
Imatinib Mesylate
1
2004
45
0.010
Why?
Probability
1
2004
320
0.010
Why?
Spectrophotometry, Ultraviolet
1
2003
44
0.010
Why?
Biotransformation
1
2003
50
0.010
Why?
Ultraviolet Rays
1
2004
203
0.010
Why?
Catheters, Indwelling
1
2004
154
0.010
Why?
Practice Patterns, Physicians'
1
2008
729
0.010
Why?
Injections, Intraventricular
1
2002
63
0.010
Why?
Ondansetron
1
2002
10
0.010
Why?
Feasibility Studies
1
2005
759
0.010
Why?
Tumor Suppressor Protein p53
1
2006
723
0.010
Why?
Pineal Gland
1
2002
18
0.010
Why?
Pinealoma
1
2002
19
0.010
Why?
Melphalan
1
2002
49
0.010
Why?
Phenobarbital
1
2002
36
0.010
Why?
Enzyme Induction
1
2002
104
0.010
Why?
Etoposide
1
2002
114
0.010
Why?
Breast Neoplasms
1
2014
2513
0.010
Why?
Cytochrome P-450 CYP3A
1
2002
60
0.010
Why?
Cranial Irradiation
1
2002
67
0.010
Why?
Pregnancy
1
2014
7174
0.010
Why?
Multivariate Analysis
1
2004
1439
0.010
Why?
Protein Binding
1
2004
1734
0.010
Why?
Cohort Studies
1
2008
4805
0.010
Why?
Models, Biological
1
2003
1458
0.010
Why?
Seizures
1
2002
874
0.010
Why?
Disease Progression
1
2002
2058
0.010
Why?
Hematopoietic Stem Cell Transplantation
1
2002
1198
0.010
Why?
BERG's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (344)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_